Half of glioblastoma patients have a subtype that doesn’t respond to any approved cancer drugs. A new experimental treatment from The Wertheim UF Scripps Institute shows promise in mouse studies. Clinical trials are coming soon.| wertheim.scripps.ufl.edu
Related News Using AI, USC researchers pioneer a potential new immunotherapy approach for treating glioblastoma August 1, 2024 An early blood test can predict survival in patients with metastatic prostate […]| Newsroom
The breakthrough by UF Health Cancer Center researchers now will be tested in a Phase 1 pediatric clinical trial for brain cancer.| cancer.ufl.edu